Trial Profile
S-1 With Cisplatin Intravenous Chemotherapy Versus S-1 Plus Cisplatin Hyperthermic Intraperitoneal Chemotherapy in Stage Ⅲ Patients After D2 Gastrectomy a Randomized Controlled Study
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2022
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 11 Jan 2016 New trial record